Functional Constipation in Children: Evaluation and Management
For children with functional constipation without alarm features, start treatment immediately with polyethylene glycol (PEG) after making a clinical diagnosis based on Rome IV criteria—extensive laboratory testing and imaging are unnecessary and should be avoided.
Diagnostic Approach
Clinical Diagnosis is Sufficient
The diagnosis of functional constipation in children is clinical and does not require laboratory tests or imaging in the absence of alarm features 1, 2. Use the Rome IV diagnostic criteria, which can be applied through history and physical examination alone 3, 1.
Essential History Elements
Focus on:
- Stool frequency and consistency (use Bristol Stool Form Scale)
- Painful or hard bowel movements
- Large diameter stools that may obstruct the toilet
- Withholding behaviors
- Fecal incontinence/soiling
- Duration of symptoms (≥1 month in infants, ≥2 months in older children per Rome IV)
Physical Examination Priorities
The physical exam should specifically assess:
- Growth parameters (to exclude organic causes)
- Abdominal examination for palpable stool or masses
- Perianal inspection for fissures, position, and appearance
- Lumbosacral region for signs of spinal abnormalities (dimples, tufts of hair, asymmetry)
- Digital rectal examination if indicated to assess for impaction, anal tone, and rectal vault size 4, 2
Red Flag Symptoms Requiring Further Investigation
Refer or investigate further if present:
- Failure to pass meconium within 48 hours of birth
- Ribbon stools
- Blood in stools (without hard stools/fissures)
- Failure to thrive or weight loss
- Fever
- Bilious vomiting
- Severe abdominal distension
- Abnormal neurological examination
- Thyroid abnormalities 1, 4
Abdominal x-rays are not useful for differentiating functional from organic constipation and should not be routinely obtained 4.
Treatment Algorithm
Step 1: Disimpaction (if present)
Before maintenance therapy, treat fecal impaction if identified. This can be accomplished with:
Step 2: Maintenance Therapy
Polyethylene glycol (PEG) is the first-line pharmacological treatment 1, 2, 5. It has the strongest evidence base and should be initiated at:
- Starting dose: 0.4-0.8 g/kg/day
- Titrate based on response
- Continue for several months, even after symptom resolution
Step 3: Second-Line Options
If PEG is insufficient or not tolerated:
- Lactulose as an alternative osmotic laxative 1, 2
- Add stimulant laxatives (bisacodyl or senna) if osmotic agents alone are inadequate 2, 5
- Administer stimulant laxatives 30 minutes after meals to synergize with the gastrocolonic response
Step 4: Non-Pharmacological Interventions (Concurrent with Medication)
Education and behavioral modification are essential components:
- Toilet training with scheduled sitting times (5-10 minutes after meals, 2-3 times daily)
- Reward systems for compliance and successful bowel movements
- Defecation diary to track progress
- Proper positioning (feet supported, knees above hips) 2, 5
Important Caveats
Dietary Modifications Have Limited Evidence
Increasing fiber and fluid intake above usual daily recommendations provides no additional benefit for treating constipation 1. While adequate baseline intake is reasonable, aggressive supplementation is not evidence-based as primary therapy.
Probiotics are not recommended as they provide no additional benefits for functional constipation treatment 1.
Long-Term Management Expectations
Educate families that:
- 40-50% of children experience at least one relapse within 5 years 4
- Treatment may need to continue for months to years
- Gradual weaning should only occur after prolonged symptom control (typically 1-2 months minimum)
- Long-term laxative use is safe—address parental concerns proactively as this is a major contributor to treatment failure 3
When to Refer to Pediatric Gastroenterology
Refer when:
- Alarm features are present suggesting organic causes
- Constipation persists despite adequate therapy with PEG and second-line agents
- Concern for Hirschsprung disease or other anatomical abnormalities
- Severe behavioral or psychological comorbidities requiring specialized management 1, 4
Follow-Up Strategy
Frequent follow-up visits improve outcomes 1. Schedule visits every 2-4 weeks initially to:
- Assess medication adherence (the primary cause of treatment failure)
- Adjust dosing based on response
- Reinforce behavioral interventions
- Address family concerns about long-term laxative safety